共 50 条
- [41] Comment to "Experience with sunitinib in hormone-resistant metastatic prostate cancer that is unresponsive to docetaxel" [J]. ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (01): : 61 - 61
- [42] Changes in phospholipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells [J]. JOURNAL OF CANCER, 2021, 12 (10): : 2893 - 2902
- [43] PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient [J]. ONKOLOGIE, 2010, 33 (1-2): : 57 - 59
- [45] FLUTAMIDE IN HORMONE-RESISTANT PROSTATIC-CANCER [J]. JOURNAL OF UROLOGY, 1990, 144 (06): : 1411 - 1414
- [46] mTOR inhibition in hormone-resistant breast cancer [J]. LANCET ONCOLOGY, 2012, 13 (06): : E239 - E239
- [47] Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study [J]. British Journal of Cancer, 1997, 76 : 93 - 99
- [49] Hormone-resistant prostate cancer: New therapies needed - The Ross/Kantoff article reviewed [J]. ONCOLOGY-NEW YORK, 2007, 21 (02): : 194 - +